Adrienne Lugo is currently Head of Sales at Sera Prognostics, where she leads national commercial strategy to expand adoption of PreTRM®, a groundbreaking test designed to identify women at risk for spontaneous preterm birth.

Throughout her 20+ year career in women’s health and diagnostics, she focused on bringing innovative, clinically meaningful solutions to market and ensuring they don’t just launch, but scale. At Sera, that mission is deeply personal and highly impactful, helping providers intervene earlier and improving outcomes for mothers and babies.

Adrienne is a Tampa native and has three wonderful children.  Adrienne is very active in the community and enjoys the outside and travels as much as possible